Status:
UNKNOWN
Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients
Lead Sponsor:
Assiut University
Conditions:
Patient Monitoring
Eligibility:
All Genders
20-50 years
Brief Summary
CO2 monitoring through non-invasive methods to provide an early warning of hypoventilation during procedural sedation.
Detailed Description
Many patients become hypoxic during endoscopic retrograde cholangiopancreatography (ERCP). Following induced sedation, hypoxia or hypercapnia may follow . Monitoring the CO2 level during respiration (...
Eligibility Criteria
Inclusion
- Adult patients aged 20-50 years.
- Males or females.
- Elective Endoscopic Retrograde Cholangiopancreatography Patients
Exclusion
- Patient with abnormal renal function test.
- Patient with history of chronic chest disease like asthma or Chronic obstructed pulmonary diseases.
- Patients with a history of systemic illness like hypertension and diabetes.
- Cardiac patients.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04481308
Start Date
October 1 2022
End Date
November 1 2022
Last Update
February 16 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicin
Asyut, Egypt
2
Samar
Asyut, Egypt